What is NDC 68071-4739?

68071-4739 is the product NDC for oseltamavir phosphate, Oseltamivir phosphate 75 mg/1 capsule, listed with the FDA by NuCare Pharmaceuticals,Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

NuCare Pharmaceuticals,Inc., NDC labeler code 68071. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for oseltamavir phosphate?

3 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

oseltamavir phosphate NDC 68071-4739

NDC codes

FDA NDC Directory

Product NDC (as listed)68071-4739Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68071-4739Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68071-4739-1	6807147390168071473901	10 CAPSULE in 1 BOX (68071-4739-1)Marketed from Jan 25, 2019

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): oseltamavir phosphate
Generic name (nonproprietary): oseltamavir phosphate
Active ingredients: Oseltamivir phosphate — 75 mg/1
Dosage form: Capsule
Route: Oral
Labeler: NuCare Pharmaceuticals,Inc.NDC labeler code 68071
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 207211
Marketing start: Sep 21, 2017
Listing expires: Dec 31, 2026
Other FDA classes: Neuraminidase Inhibitors (Mechanism)
Identifiers: Product ID 68071-4739_2d7d2d42-1baa-e20a-e063-6394a90a15ccSPL ID 2d7d2d42-1baa-e20a-e063-6394a90a15ccSPL set ID 80511c6f-88b9-62d3-e053-2991aa0ab936RxCUI 312122UNII 4A3O49NGEZUPC 0368071473919
Pharmacologic class: Neuraminidase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468071473901 followed by a unit qualifier and the quantity

Package 68071-4739-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 6, 2025.

Indications (excerpt from the label)

Oseltamivir phosphate capsules USP, is an influenza neuraminidase inhibitor (NAI) indicated for: • Treatment of acute, uncomplicated influenza A and B in patients 2 weeks of age and older who have been symptomatic for no more than 48 hours. ( 1.1 ) • Prophylaxis of influenza A and B in patients 1 year and older. ( 1.2 ) Limitations of Use: • Not a substitute for annual influenza vaccination. ( 1.3 ) • Consider available information on influenza drug susceptibility patterns and treatment effects when deciding whether to use. ( 1.3 ) • Not recommended for patients with end-stage renal disease not undergoing dialysis. ( 1.3 ) 1.1 Treatment of Influenza Oseltamivir phosphate capsule is indicated…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 68071-4739

What is NDC 68071-4739?: 68071-4739 is the product NDC for oseltamavir phosphate, Oseltamivir phosphate 75 mg/1 capsule, listed with the FDA by NuCare Pharmaceuticals,Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: oseltamavir phosphate.
What is the active ingredient?: Oseltamivir phosphate.
Who is the labeler?: NuCare Pharmaceuticals,Inc., NDC labeler code 68071. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for oseltamavir phosphate?: 3 other product NDCs are listed under this name. See all oseltamavir phosphate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other oseltamavir phosphate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
oseltamavir phosphate	Oseltamivir phosphate 45 mg/1	CapsuleOral	NuCare Pharmaceuticals, Inc.	68071-3741	68071-3741-01
oseltamavir phosphate	Oseltamivir phosphate 75 mg/1	CapsuleOral	Proficient Rx LP	71205-107	71205-0107-1071205-0107-3071205-0107-60+1 more
oseltamavir phosphate	Oseltamivir phosphate 45 mg/1	CapsuleOral	Proficient Rx LP	71205-417	71205-0417-10

Other NDCs under ANDA 207211

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 207211
Product	Strength	Form · route	Labeler	Product NDC
oseltamavir phosphate	Oseltamivir phosphate 45 mg/1	CapsuleOral	NuCare Pharmaceuticals, Inc.	68071-3741
oseltamavir phosphate	Oseltamivir phosphate 75 mg/1	CapsuleOral	Proficient Rx LP	71205-107
oseltamavir phosphate	Oseltamivir phosphate 45 mg/1	CapsuleOral	Proficient Rx LP	71205-417
oseltamivir phosphate	Oseltamivir phosphate 30 mg/1	CapsuleOral	Macleods Pharmaceuticals Limited	33342-256
oseltamivir phosphate	Oseltamivir phosphate 45 mg/1	CapsuleOral	Macleods Pharmaceuticals Limited	33342-257
oseltamivir phosphate	Oseltamivir phosphate 75 mg/1	CapsuleOral	Macleods Pharmaceuticals Limited	33342-258